Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment.

This article outlines an evidence-informed, interdisciplinary, multidimensional, comprehensive action plan for the American Urogynecologic Society to improve care of women with overactive bladder (OAB) while minimizing treatment-related adverse events, including cognitive impairment. It is a "call to action" to advance basic, translational, and clinical research and summarizes initiatives developed at the State-of-the-Science Conference on OAB and Cognitive Impairment to (1) develop framework for a new OAB treatment approach in women, (2) define research gaps and future research priorities, (3) champion health equity and diversity considerations in OAB treatment, (4) foster community and promote education to remove stigma surrounding OAB and urinary incontinence, and (5) elevate visibility and impact of OAB, by creating partnerships through education and engagement with health care professionals, industry, private and public payers, funding agencies, and policymakers.

Urogynecology (Hagerstown, Md.). 2022 Oct 21 [Epub]

Tatiana V D Sanses, Jacqueline Zillioux, Rachel A High, Katherine L Dengler, Mary F Ackenbom, Catherine E DuBeau, Marianna Alperin, Adrian Wagg, Lori A Birder, Chantale Dumoulin, Tamara Bavendam

From the Department of Obstetrics and Gynecology, Howard University College of Medicine, Washington, DC., Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH., Women's Health, University of Texas at Austin Dell Medical School, Austin, TX., Walter Reed National Military Medical Center, Bethesda, MD., Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Hanover, NH., University of California San Diego, La Jolla, CA., University of Alberta, Edmonton, Alberta, Canada., University of Pittsburgh School of Medicine, Pittsburgh, PA., Université de Montréal, Montreal (Quebec), Canada., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.